GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vireo Growth Inc (FRA:0ZF) » Definitions » Enterprise Value

Vireo Growth (FRA:0ZF) Enterprise Value : €136.22 Mil (As of May. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Vireo Growth Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vireo Growth's Enterprise Value is €136.22 Mil. Vireo Growth's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €12.99 Mil. Therefore, Vireo Growth's EV-to-EBIT ratio for today is 10.48.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vireo Growth's Enterprise Value is €136.22 Mil. Vireo Growth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €16.10 Mil. Therefore, Vireo Growth's EV-to-EBITDA ratio for today is 8.46.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vireo Growth's Enterprise Value is €136.22 Mil. Vireo Growth's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €92.06 Mil. Therefore, Vireo Growth's EV-to-Revenue ratio for today is 1.48.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Vireo Growth's Enterprise Value is €136.22 Mil. Vireo Growth's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was €-20.38 Mil. Therefore, Vireo Growth's EV-to-FCF ratio for today is -6.68.


Vireo Growth Enterprise Value Historical Data

The historical data trend for Vireo Growth's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vireo Growth Enterprise Value Chart

Vireo Growth Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.95 256.14 136.32 86.36 183.41

Vireo Growth Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.36 124.06 128.95 161.62 183.41

Competitive Comparison of Vireo Growth's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vireo Growth's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Enterprise Value falls into.


;
;

Vireo Growth Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Vireo Growth's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Vireo Growth's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vireo Growth  (FRA:0ZF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Vireo Growth's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=136.224/12.993
=10.48

Vireo Growth's current Enterprise Value is €136.22 Mil.
Vireo Growth's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €12.99 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Vireo Growth's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=136.224/16.102
=8.46

Vireo Growth's current Enterprise Value is €136.22 Mil.
Vireo Growth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €16.10 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Vireo Growth's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=136.224/92.056
=1.48

Vireo Growth's current Enterprise Value is €136.22 Mil.
Vireo Growth's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €92.06 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Vireo Growth's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=136.224/-20.381
=-6.68

Vireo Growth's current Enterprise Value is €136.22 Mil.
Vireo Growth's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-20.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vireo Growth Enterprise Value Related Terms

Thank you for viewing the detailed overview of Vireo Growth's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vireo Growth Business Description

Traded in Other Exchanges
Address
207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Inc is a cannabis company whose mission is to provide safe access, quality products, and value to its customers while supporting its local communities through active participation and restorative justice programs. The company's operating results in one business segment: the cultivation, production, and sale of cannabis.

Vireo Growth Headlines

No Headlines